Gasset-Rosa F, Chillon-Marinas C, Goginashvili A, et al. Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport. Neuron. 2017;94(1):48-57.e4. doi:10.1016/j.neuron.2017.03.027
Mitt M, Kals M, Pärn K, et al. Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel. Eur J Hum Genet. 2017;25(7):869-876. doi:10.1038/ejhg.2017.51
Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34. doi:10.1186/s13073-017-0424-2
Merkle FT, Ghosh S, Kamitaki N, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545(7653):229-233. doi:10.1038/nature22312
Chen JH, Pelka K, Hacohen N. Heavy Metal Enlightens Tumor Immunity. Cell. 2017;169(4):567-569. doi:10.1016/j.cell.2017.04.017
Lazaridis I, Reich D. Failure to replicate a genetic signal for sex bias in the steppe migration into central Europe. Proc Natl Acad Sci U S A. 2017;114(20):E3873-E3874. doi:10.1073/pnas.1704308114
Manguso RT, Pope HW, Zimmer MD, et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017;547(7664):413-418. doi:10.1038/nature23270
Sandoval GJ, Hahn WC. Going beyond genetics to discover cancer targets. Genome Biol. 2017;18(1):95. doi:10.1186/s13059-017-1238-7
Tachmazidou I, Süveges D, Min JL, et al. Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits. Am J Hum Genet. 2017;100(6):865-884. doi:10.1016/j.ajhg.2017.04.014
Pedersen BS, Collins RL, Talkowski ME, Quinlan AR. Indexcov: fast coverage quality control for whole-genome sequencing. Gigascience. 2017;6(11):1-6. doi:10.1093/gigascience/gix090